Administration of Ethylnitrosourea to Neonate Hamsters Increases Growth and Frequency of SV40-Induced Fibrosarcomas

Sukhendra Choudhury, Anthony E. Pegg, John W. Kreider, Donald R. Mayo, Mary K. Howett

Research output: Contribution to journalArticle

Abstract

The in vivo interaction between the chemical carcinogen ethylnitrosourea (ENU) and the oncogenic simian virus 40 (SV40) was studied. Inbred newborn Syrian golden hamsters were injected subcutaneously with SV40 (5 × 106 plaque-forming units), ENU (0.5% solution, 125 or 25 mg/kg body wt), or equal mixtures of the two. Animals that received SV40 and ENU developed more tumors (100% vs 52%) within a shorter latent period (10 weeks vs 18 weeks) than animals that received SV40 alone. Animals given SV40 and ENU showed increased mortality and increased metastatic tumors (54.2% vs 30.8%) compared with those given SV40 alone. The SV40 and ENU group also exhibited multiple (> 10 nodules) pulmonary metastases (33.3% vs 7.7%) and metastases in multiple organs (12.5% vs 0%) compared with animals injected with SV40 alone. No difference in primary tumor size, histology, and SV40 T-antigen content was detected between SV40- and SV40/ENU-induced tumors. Four weeks after SV40 or SV40 plus ENU treatment, animals were challenged intradermally with 2.7 × 106 SV40-transformed hamster cells. Five weeks after challenge, 89.5% of the animals treated with SV40 and ENU and 45.4% of animals treated with SV40 developed tumors at the challenge site. Newborn animals given SV40 and ENU developed larger tumors at the challenge site (P < 0.002) than newborns treated with SV40 alone. Thus, administration of ENU to hamsters during the neonatal stage of development produced a long-lasting systemic effect that enhanced tumor development by transplanted SV40-transformed hamster cells.

Original languageEnglish (US)
Pages (from-to)72-77
Number of pages6
JournalProceedings of the Society for Experimental Biology and Medicine
Volume192
Issue number1
DOIs
StatePublished - Oct 1989

Fingerprint

Ethylnitrosourea
Simian virus 40
Fibrosarcoma
Viruses
Cricetinae
Growth
Animals
Tumors
Neoplasms
Oncogenic viruses
Parainfluenza Virus 5
Cells
Neoplasm Metastasis
Newborn Animals

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

@article{74bdec7f67a5429f992c35ed631dd9d3,
title = "Administration of Ethylnitrosourea to Neonate Hamsters Increases Growth and Frequency of SV40-Induced Fibrosarcomas",
abstract = "The in vivo interaction between the chemical carcinogen ethylnitrosourea (ENU) and the oncogenic simian virus 40 (SV40) was studied. Inbred newborn Syrian golden hamsters were injected subcutaneously with SV40 (5 × 106 plaque-forming units), ENU (0.5{\%} solution, 125 or 25 mg/kg body wt), or equal mixtures of the two. Animals that received SV40 and ENU developed more tumors (100{\%} vs 52{\%}) within a shorter latent period (10 weeks vs 18 weeks) than animals that received SV40 alone. Animals given SV40 and ENU showed increased mortality and increased metastatic tumors (54.2{\%} vs 30.8{\%}) compared with those given SV40 alone. The SV40 and ENU group also exhibited multiple (> 10 nodules) pulmonary metastases (33.3{\%} vs 7.7{\%}) and metastases in multiple organs (12.5{\%} vs 0{\%}) compared with animals injected with SV40 alone. No difference in primary tumor size, histology, and SV40 T-antigen content was detected between SV40- and SV40/ENU-induced tumors. Four weeks after SV40 or SV40 plus ENU treatment, animals were challenged intradermally with 2.7 × 106 SV40-transformed hamster cells. Five weeks after challenge, 89.5{\%} of the animals treated with SV40 and ENU and 45.4{\%} of animals treated with SV40 developed tumors at the challenge site. Newborn animals given SV40 and ENU developed larger tumors at the challenge site (P < 0.002) than newborns treated with SV40 alone. Thus, administration of ENU to hamsters during the neonatal stage of development produced a long-lasting systemic effect that enhanced tumor development by transplanted SV40-transformed hamster cells.",
author = "Sukhendra Choudhury and Pegg, {Anthony E.} and Kreider, {John W.} and Mayo, {Donald R.} and Howett, {Mary K.}",
year = "1989",
month = "10",
doi = "10.3181/00379727-192-42958",
language = "English (US)",
volume = "192",
pages = "72--77",
journal = "Experimental Biology and Medicine",
issn = "1535-3702",
publisher = "SAGE Publications Ltd",
number = "1",

}

Administration of Ethylnitrosourea to Neonate Hamsters Increases Growth and Frequency of SV40-Induced Fibrosarcomas. / Choudhury, Sukhendra; Pegg, Anthony E.; Kreider, John W.; Mayo, Donald R.; Howett, Mary K.

In: Proceedings of the Society for Experimental Biology and Medicine, Vol. 192, No. 1, 10.1989, p. 72-77.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Administration of Ethylnitrosourea to Neonate Hamsters Increases Growth and Frequency of SV40-Induced Fibrosarcomas

AU - Choudhury, Sukhendra

AU - Pegg, Anthony E.

AU - Kreider, John W.

AU - Mayo, Donald R.

AU - Howett, Mary K.

PY - 1989/10

Y1 - 1989/10

N2 - The in vivo interaction between the chemical carcinogen ethylnitrosourea (ENU) and the oncogenic simian virus 40 (SV40) was studied. Inbred newborn Syrian golden hamsters were injected subcutaneously with SV40 (5 × 106 plaque-forming units), ENU (0.5% solution, 125 or 25 mg/kg body wt), or equal mixtures of the two. Animals that received SV40 and ENU developed more tumors (100% vs 52%) within a shorter latent period (10 weeks vs 18 weeks) than animals that received SV40 alone. Animals given SV40 and ENU showed increased mortality and increased metastatic tumors (54.2% vs 30.8%) compared with those given SV40 alone. The SV40 and ENU group also exhibited multiple (> 10 nodules) pulmonary metastases (33.3% vs 7.7%) and metastases in multiple organs (12.5% vs 0%) compared with animals injected with SV40 alone. No difference in primary tumor size, histology, and SV40 T-antigen content was detected between SV40- and SV40/ENU-induced tumors. Four weeks after SV40 or SV40 plus ENU treatment, animals were challenged intradermally with 2.7 × 106 SV40-transformed hamster cells. Five weeks after challenge, 89.5% of the animals treated with SV40 and ENU and 45.4% of animals treated with SV40 developed tumors at the challenge site. Newborn animals given SV40 and ENU developed larger tumors at the challenge site (P < 0.002) than newborns treated with SV40 alone. Thus, administration of ENU to hamsters during the neonatal stage of development produced a long-lasting systemic effect that enhanced tumor development by transplanted SV40-transformed hamster cells.

AB - The in vivo interaction between the chemical carcinogen ethylnitrosourea (ENU) and the oncogenic simian virus 40 (SV40) was studied. Inbred newborn Syrian golden hamsters were injected subcutaneously with SV40 (5 × 106 plaque-forming units), ENU (0.5% solution, 125 or 25 mg/kg body wt), or equal mixtures of the two. Animals that received SV40 and ENU developed more tumors (100% vs 52%) within a shorter latent period (10 weeks vs 18 weeks) than animals that received SV40 alone. Animals given SV40 and ENU showed increased mortality and increased metastatic tumors (54.2% vs 30.8%) compared with those given SV40 alone. The SV40 and ENU group also exhibited multiple (> 10 nodules) pulmonary metastases (33.3% vs 7.7%) and metastases in multiple organs (12.5% vs 0%) compared with animals injected with SV40 alone. No difference in primary tumor size, histology, and SV40 T-antigen content was detected between SV40- and SV40/ENU-induced tumors. Four weeks after SV40 or SV40 plus ENU treatment, animals were challenged intradermally with 2.7 × 106 SV40-transformed hamster cells. Five weeks after challenge, 89.5% of the animals treated with SV40 and ENU and 45.4% of animals treated with SV40 developed tumors at the challenge site. Newborn animals given SV40 and ENU developed larger tumors at the challenge site (P < 0.002) than newborns treated with SV40 alone. Thus, administration of ENU to hamsters during the neonatal stage of development produced a long-lasting systemic effect that enhanced tumor development by transplanted SV40-transformed hamster cells.

UR - http://www.scopus.com/inward/record.url?scp=0024419616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024419616&partnerID=8YFLogxK

U2 - 10.3181/00379727-192-42958

DO - 10.3181/00379727-192-42958

M3 - Article

C2 - 2552456

AN - SCOPUS:0024419616

VL - 192

SP - 72

EP - 77

JO - Experimental Biology and Medicine

JF - Experimental Biology and Medicine

SN - 1535-3702

IS - 1

ER -